Fierce Biotech April 30, 2024
GE HealthCare missed its revenue goals for the first quarter after sales in China dipped 11%, compared to the boosts the company saw in the region during the same period the year prior.
Overall, revenues declined 1% to $4.6 billion, or just about flat when accounting for changes in international currencies. GE HealthCare hopes to make up ground in the remainder of the year, and is sticking to its previous sales growth projections of about 4% year-over-year.
Describing the first quarter of 2023 as the company’s toughest comparison of the year, CEO Peter Arduini said things will get better in the latter half of the calendar.
“Q1 was impacted by, fundamentally, two items,” Arduini said on a call with investors....
Today's Sponsors
Today's Sponsor